Trending anti-E7 serology predicts mortality and recurrence of HPV-associated cancers of the oropharynx

Authors

Luke Johnson, University of Louisville
Dat T Ha, University of Louisville
Melissa B Hall, University of Louisville
Gregory Shoemaker, University of Louisville
Paul A Bevins, University of Louisville
John Strickley, Washington University School of Medicine in St. Louis
Shadmehr Demehri, Harvard University
Rebecca A Redman, University of Louisville
Joongho Joh, University of Louisville

Journal

Journal of Oncology

Publication Date

9-26-2022

Volume

2022

First Page

3107990

Document Type

Open Access Publication

DOI

10.1155/2022/3107990

Rights and Permissions

Johnson L, Ha DT, Hall MB, Shoemaker G, Bevins PA, Strickley J, Demehri S, Redman RA, Joh J. Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx. J Oncol. 2022 Sep 26;2022:3107990. doi: 10.1155/2022/3107990 Copyright © 2022 Luke Johnson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Johnson, Luke; Ha, Dat T; Hall, Melissa B; Shoemaker, Gregory; Bevins, Paul A; Strickley, John; Demehri, Shadmehr; Redman, Rebecca A; and Joh, Joongho, "Trending anti-E7 serology predicts mortality and recurrence of HPV-associated cancers of the oropharynx." Journal of Oncology. 2022, 3107990 (2022).
https://digitalcommons.wustl.edu/oa_4/501